Fundraising Fox

Goodwin Biotechnology

Plantation, US · Delaware corporation

BiotechHealthtech

Founders & leadership

KP
Karl PintoExecutive
SV
Steven VorgityExecutive
SS
SooYoung S. LeeChief Operating Officer and Secretary
CM
Cesar MenezesNamed on SEC filing
ME
Maria Emila MenezesNamed on SEC filing
JL
Jerry LiaoNamed on SEC filing
SK
Sunil K. AgarwalFinancial Controller and Treasurer

Board

NP
Nikhil PuriBoard director
BP
Brandon PriceBoard director
KP
Kent PayneBoard director
DM
Divya MenezesBoard director

Reported raises · per SEC filings

Form D private placements

$30.7M disclosed across 4 rounds · 2019–2025

▶$2MraisedJan 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Karl PintoExecutive Officer, Director
  • Nikhil PuriDirector
  • Brandon PriceDirector
  • Kent PayneDirector
  • Divya MenezesDirector
  • Steven VorgityExecutive Officer
Offering amount
$4M
Amount sold
$2M
Minimum investment
$1M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$3MraisedNov 2024 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Karl PintoExecutive Officer, Director
  • Nikhil PuriDirector
  • Kent PayneDirector
  • Divya MenezesDirector
  • Steven VorgityExecutive Officer
  • Brandon PriceDirector
Offering amount
$3M
Amount sold
$3M
Minimum investment
$3M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$5MraisedOct 2023 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kent PayneDirector
  • Karl PintoDirector
  • Darrin SchellinExecutive Officer, Director
  • Divya MenezesDirector
  • Nikhil PuriDirector
  • Brandon PriceDirector
  • Steven VorgityExecutive Officer
Offering amount
$5M
Amount sold
$5M
Minimum investment
$522.5K
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$20.7MraisedApr 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karl PintoExecutive Officer, Director
  • SooYoung S. LeeExecutive Officer
  • Sunil K. AgarwalExecutive Officer
  • Cesar MenezesDirector
  • Divya MenezesDirector
  • Maria Emila MenezesDirector
  • Nikhil PuriDirector
  • Jerry LiaoDirector
Offering amount
$20.7M
Amount sold
$20.7M
Sales commissions
$600K
Placement agents
Cornelius P. McCarthy III
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Goodwin Biotechnology Secures Significant Institutional Investment in New Round of Growth Capital Financingprnewswire.com · Apr 2019

Frequently asked questions

How much funding has Goodwin Biotechnology raised?
Goodwin Biotechnology has disclosed $30.7M raised across 4 rounds.
Where is Goodwin Biotechnology headquartered?
Goodwin Biotechnology is headquartered in Plantation, US.